ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in Milano, Lombardia

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Breast Cancer

Prostate Cancer trials near Milano, Lombardia, ITA:

Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer (RAPSON)

prednisone in symptomatic bone-only metastatic castration-resistant prostate cancer (mCRPC)Open-label, randomized phase II trial in ...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Docetaxel
Drug: Radium-223

Phase 2

Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori

Milano, Italy and 14 other locations

and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: abiraterone acetate
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Milano, Italy and 131 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Cremona, Italy and 220 other locations

Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate...

Active, not recruiting
Metastasis From Malignant Tumor of Prostate
Drug: Abiraterone with Prednisone or Enzalutamide
Drug: 177Lu-PSMA-I&T

Phase 3

Curium

Milan, Italy and 51 other locations

pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents (NHAs) in patients with Metastatic Prostate...

Enrolling
Metastatic Prostate Cancer
Drug: AZD5305
Drug: Enzalutamide

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Milano, Italy and 26 other locations

prednisone/prednisolone compared with placebo plus abiraterone and prednisone/prednisolone in participants with metastatic castrate-resistant prostate...

Active, not recruiting
Metastatic Prostate Cancer
Drug: Ipatasertib
Drug: Placebo

Phase 3

Roche
Roche

Milano, Lombardia, Italy and 183 other locations

is to evaluate the effectiveness, safety and tolerability of nivolumab followed by ipilimumab, in subjects with metastatic castration resistant prostate...

Active, not recruiting
Prostate Cancer
Biological: Nivolumab
Biological: Ipilimumab

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Milano, Italy and 59 other locations

The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progressio...

Active, not recruiting
Metastatic Hormone Sensitive Prostate Cancer
Drug: Placebo
Drug: Enzalutamide

Phase 3

Astellas
Astellas

Milano, Lombardia, Italy and 202 other locations

hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with on ...

Active, not recruiting
Metastatic Prostate Cancer
Prostate Adenocarcinoma
Drug: Cabozantinib
Drug: Abiraterone Acetate

Phase 3

Exelixis
Exelixis

Milan, Italy and 272 other locations

The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA...

Enrolling
Metastatic Castration-Sensitive Prostate Cancer
Drug: Abiraterone Acetate
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Milano, Italy and 385 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems